NEW: World Trade TARIFFS Simulator!
NEW: 2023 Data and Complexity Rankings
Sign In
Pricing

2023
Exports $533MWorld Rnk 49 / 225
Flag Rnk 37 / 96
2023
Destination $21.8M Singapore
2022 - 2023
FASTEST GROWING MARKET $21.8MHong Kong
2023
PRODUCT COMPLEXITY IN Pharmaceutical products1.25Rnk 89 / 1025
2023
Imports $2.27BWorld Rnk 46 / 226
Flag Rnk 21 / 96
2023
Origin $88.9M United States
2022 - 2023
FASTEST GROWING ORIGIN $88.9MUnited States
2023
ECONOMIC COMPLEXITY of Malaysia1.04Rnk 27 / 132

About

Exports In 2023, Malaysia exported $533M in Pharmaceutical products, making it the 49th largest exporter of Pharmaceutical products in the world. At the same year, Pharmaceutical products was the 37th most exported product in Malaysia. The main destination of Pharmaceutical products exports from Malaysia are: Singapore ($99.1M), United States ($96.1M), Hong Kong ($62M), Brunei ($57.3M), and China ($26M).

The fastest growing export markets for Pharmaceutical products of Malaysia between 2022 and 2023 were Hong Kong ($21.8M), South Korea ($19.3M), and China ($19.3M).

Imports In 2023, Malaysia imported $2.27B in Pharmaceutical products, becoming the 46th largest importer of Pharmaceutical products in the world. At the same year, Pharmaceutical products was the 21st most imported product in Malaysia. Malaysia imports Pharmaceutical products primarily from: United States ($288M), Germany ($284M), Singapore ($189M), Switzerland ($185M), and Ireland ($161M).

The fastest growing import markets in Pharmaceutical products for Malaysia between 2022 and 2023 were United States ($88.9M), Singapore ($76.6M), and Ireland ($22.9M).

COMPANIES In 2023, leading companies such as Tesla (2) were at the forefront of shipping Pharmaceutical products from Malaysia to the United States.

Latest Trends

November 2024

About

Overview In November 2024 Malaysia's Pharmaceutical products exports accounted up to MYR190M and imports accounted up to MYR931M, resulting in a negative trade balance of MYR741M. Between November 2023 and November 2024 the exports of Malaysia's   Pharmaceutical products have decreased by MYR-6.64M (-3.38%) from MYR196M to MYR190M, while imports increased by MYR43.9M (4.95%) from MYR887M to MYR931M.

Destinations In November 2024, Pharmaceutical products were exported mostly to United States (MYR41.1M), Brunei (MYR20.8M), Singapore (MYR19M), Australia (MYR16.8M), and Hong Kong (MYR13.2M), and were imported mostly from Germany (MYR126M), Singapore (MYR89.7M), United States (MYR87.1M), Ireland (MYR87M), and France (MYR56.9M).

Growth In November 2024, the decrease in Pharmaceutical products's year-by-year exports was explained primarily by a decrease in exports to United States (MYR-36M or -92.8%), Australia (MYR-8.07M or -33%), and Cambodia (MYR-5.42M or -93.9%). In November 2024, the increase in Pharmaceutical products's year-by-year imports was explained primarily by an increase in imports from United States (MYR29.6M or 46.7%), India (MYR27.1M or 91.7%), and Italy (MYR26.6M or 163%).

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (November 2023 - November 2024)MYR-6.64M(-3.38%)
IMPORT GROWTH (November 2023 - November 2024)MYR43.9M(4.95%)
MAIN DESTINATION (November 2024)United StatesMYR41.1M

This section shows Pharmaceutical products's exports and imports data at subnational level for Malaysia. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Pharmaceutical products over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$533M
IMPORTS (2023)$2.27B
NET TRADE (2023)-$1.73B

In 2023, Malaysia exported $533M in Pharmaceutical products. The main destinations of Malaysia exports on Pharmaceutical products were Singapore ($99.1M), United States ($96.1M), Hong Kong ($62M), Brunei ($57.3M), and China ($26M).

In 2023, Malaysia imported $2.27B in Pharmaceutical products, mainly from United States ($288M), Germany ($284M), Singapore ($189M), Switzerland ($185M), and Ireland ($161M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Pharmaceutical products EXPORT MARKETS FOR Malaysia WERE (2022 - 2023):
Hong Kong$21.8M (54.2%)
South Korea$19.3M (1.55k%)
China$19.3M (290%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Pharmaceutical products BY Malaysia WERE (2022 - 2023):
Nigeria-$41.3M (-90%)
United States-$17.6M (-15.5%)
Australia-$15.6M (-57.2%)
Explore Visualizations

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Malaysia's main exporting competitors in Pharmaceutical products were:
Germany $115B
United States $100B
Ireland $92B
In 2023, Malaysia's main importing competitors in Pharmaceutical products were:
United States $170B
Germany $71.1B
Switzerland $58.2B

Explore Visualizations

Trade Value of Pharmaceutical products by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $80.8M
TOP IMPORT POTENTIALGermany+ $117M

Pharmaceutical products’s highest export potential is United States. With an export gap of $80.8M.   Pharmaceutical products’s highest import potential is Germany with an import gap of $117M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms